NCT05015816View on ClinicalTrials.gov

MoleGazer Development Feasibility Study

NAActive, not recruitingINTERVENTIONAL

Enrollment

374

Participants

Timeline

Start Date

September 13, 2021

Primary Completion Date

February 28, 2024

Study Completion Date

February 28, 2026

Conditions

Melanoma (Skin)Moles Multiple Benign

Interventions

DIAGNOSTIC_TEST

Total body photography

3 monthly TBP imaging

Trial Locations (1)

OX3 7LE

Churchill Hospital, Headington

All Listed Sponsors

collaborator

University of Southampton

OTHER

lead

Oxford University Hospitals NHS Trust

OTHER